Literature DB >> 32309109

Multifarious cholesterol lowering potential of lactic acid bacteria equipped with desired probiotic functional attributes.

Bilqeesa Bhat1, Bijender Kumar Bajaj1.   

Abstract

Lactic acid bacteria (LAB) isolates possessed functional probiotic attributes, such as high hydrophobicity and autoaggregation ability, coaggregation capability with bacterial pathogens, antimicrobial activity, antioxidant potential, and hypocholesterolemic effects. Selected potential probiotic LAB, i.e. Lactobacillus paracasei M3, L. casei M5, L. paracasei M7, and few others were studied for their ability to lower cholesterol using a number of methods viz. cholesterol assimilation, bile salt deconjugation, cholesterol co-precipitation, cholesterol adhesion to probiotic cell wall, and miceller sequestration of cholesterol. L. casei M5 showed maximum bile salt hydrolase (BSH) activity, and released 57.63 nmol of glycine/min, and was closely followed by LAB isolate M9 which generated 52.12 nmol of glycine/min. Sodium glycocholate was deconjugated by L. casei M5 to produce 27.77 μmol/mL of cholic acid, while other isolates produced 20-26 μmol/mL of cholic acid. Cholesterol was assimilated significantly by isolate M6 (82.15%) and L. casei M5 (76.51%). L. casei M5 showed higher cholesterol co-precipitation ability (50.16 μg/mL) as compared to other LAB isolates (33-44 μg/mL). Miceller cholesterol concentration was reduced maximally by LAB isolate M8 (87.5%), followed by isolates M5 (84.75%), M9 (84%), M10 (80%), and M37 (79%). Higher cell wall adhesion of cholesterol was realized by L. casei M5 (42.48 μg/mL) than other LAB isolates (30-40 μg/mL). Selected LAB probiotics demonstrated short chain fatty acid (acetate, propionate, and butyrate) producing ability, yet another way of probiotics-mediated cholesterol lowering. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Bile salt hydrolase; Hypocholesterolemia; Lactobacillus casei; Lactobacillus paracasei; Probiotics

Year:  2020        PMID: 32309109      PMCID: PMC7150668          DOI: 10.1007/s13205-020-02183-8

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  32 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  Determining the probiotic potential of cholesterol-reducing Lactobacillus and Weissella strains isolated from gherkins (fermented cucumber) and south Indian fermented koozh.

Authors:  Marimuthu Anandharaj; Balayogan Sivasankari; Rajendran Santhanakaruppu; Muthusamy Manimaran; Rizwana Parveen Rani; Subramaniyan Sivakumar
Journal:  Res Microbiol       Date:  2015-04-01       Impact factor: 3.992

3.  Functional Characterization of Potential Probiotic Lactic Acid Bacteria Isolated from Kalarei and Development of Probiotic Fermented Oat Flour.

Authors:  Mahak Gupta; Bijender Kumar Bajaj
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

4.  Antibiotic sensitivity pattern of indigenous lactobacilli isolated from curd and human milk samples.

Authors:  Chetan Sharma; Sachin Gulati; Nishchal Thakur; Brij Pal Singh; Sanjolly Gupta; Simranpreet Kaur; Santosh Kumar Mishra; Anil Kumar Puniya; Jatinder Pal Singh Gill; Harsh Panwar
Journal:  3 Biotech       Date:  2017-04-25       Impact factor: 2.406

5.  Bile Salt Hydrolase (Bsh) Activity Screening of Lactobacilli: In Vitro Selection of Indigenous Lactobacillus Strains with Potential Bile Salt Hydrolysing and Cholesterol-Lowering Ability.

Authors:  Rajesh Kumar; Sunita Grover; Virender Kumar Batish
Journal:  Probiotics Antimicrob Proteins       Date:  2012-09       Impact factor: 4.609

6.  Phytase-Producing Potential and Other Functional Attributes of Lactic Acid Bacteria Isolates for Prospective Probiotic Applications.

Authors:  Syed Tabia Andrabi; Bilqeesa Bhat; Mahak Gupta; Bijender Kumar Bajaj
Journal:  Probiotics Antimicrob Proteins       Date:  2016-09       Impact factor: 4.609

7.  Strain-specific probiotics properties of Lactobacillus fermentum, Lactobacillus plantarum and Lactobacillus brevis isolates from Brazilian food products.

Authors:  Cíntia Lacerda Ramos; Line Thorsen; Rosane Freitas Schwan; Lene Jespersen
Journal:  Food Microbiol       Date:  2013-04-15       Impact factor: 5.516

8.  Hypocholesterolemic and bioactive potential of exopolysaccharide from a probiotic Enterococcus faecium K1 isolated from kalarei.

Authors:  Bilqeesa Bhat; Bijender Kumar Bajaj
Journal:  Bioresour Technol       Date:  2018-02-20       Impact factor: 9.642

9.  Aggregation, adhesion and efficacy studies of probiotic candidate Pediococcus acidilactici NCDC 252: a strain of dairy origin.

Authors:  Raman Kumar; Poonam Bansal; Jasbir Singh; Suman Dhanda; Jitender Kumar Bhardwaj
Journal:  World J Microbiol Biotechnol       Date:  2019-12-20       Impact factor: 3.312

Review 10.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03
View more
  3 in total

1.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

2.  In vitro Evaluation of the Anti-hypercholesterolemic Effect of Lactobacillus Isolates From Various Sources.

Authors:  Raymond Rubianto Tjandrawinata; Medicia Kartawijaya; Apriliana Wahyu Hartanti
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

Review 3.  The effect of probiotics on lipid profile & anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials.

Authors:  Amir Reza Moravejolahkami; Mohammad Ali Hojjati Kermani; Zakiyeh Balouch Zehi; Seyed Mohammad Sadegh Mirenayat; Marjan Mansourian
Journal:  J Diabetes Metab Disord       Date:  2021-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.